These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9842895)

  • 1. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis.
    Constantin G; Brocke S; Izikson A; Laudanna C; Butcher EC
    Eur J Immunol; 1998 Nov; 28(11):3523-9. PubMed ID: 9842895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor.
    Constantin G; Laudanna C; Brocke S; Butcher EC
    J Immunol; 1999 Jan; 162(2):1144-9. PubMed ID: 9916745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ; Du C; Sriram S
    J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock.
    Gyurkovska V; Ivanovska N
    Eur J Pharmacol; 2015 Mar; 751():118-26. PubMed ID: 25666385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of primary T-cell responses and induction of alloantigen-specific hyporesponsiveness in vitro by the Janus kinase inhibitor tyrphostin AG490.
    Säemann MD; Böhmig GA; Osterreicher CH; Staffler G; Diakos C; Krieger PM; Hörl WH; Stockinger H; Zlabinger GJ
    Transplantation; 2000 Oct; 70(8):1215-25. PubMed ID: 11063344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490.
    Higuchi T; Shiraishi T; Shirakusa T; Hirayama S; Shibaguchi H; Kuroki M; Hiratuka M; Yamamoto S; Iwasaki A; Kuroki M
    J Heart Lung Transplant; 2005 Oct; 24(10):1557-64. PubMed ID: 16210130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice.
    Du C; Bright JJ; Sriram S
    J Neuroimmunol; 2001 Mar; 114(1-2):69-79. PubMed ID: 11240017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice.
    Gyurkovska V; Stefanova T; Dimitrova P; Danova S; Tropcheva R; Ivanovska N
    Inflammation; 2014 Aug; 37(4):995-1005. PubMed ID: 24473905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-Stat pathway inhibitor.
    Davoodi-Semiromi A; Hassanzadeh A; Wasserfall CH; Droney A; Atkinson M
    J Clin Immunol; 2012 Oct; 32(5):1038-47. PubMed ID: 22661285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556.
    Brenner T; Poradosu E; Soffer D; Sicsic C; Gazit A; Levitzki A
    Exp Neurol; 1998 Dec; 154(2):489-98. PubMed ID: 9878184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.
    Davoodi-Semiromi A; Wasserfall CH; Hassanzadeh A; Cooper-DeHoff RM; Wabitsch M; Atkinson M
    Immunogenetics; 2013 Jan; 65(1):83-90. PubMed ID: 23081744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis.
    Muthian G; Raikwar HP; Johnson C; Rajasingh J; Kalgutkar A; Marnett LJ; Bright JJ
    J Clin Immunol; 2006 Jan; 26(1):73-85. PubMed ID: 16418805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
    Berghmans N; Dillen C; Heremans H
    J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial approach to identification of tyrphostin inhibitors of cytokine signaling.
    Gu L; Zhuang H; Safina B; Xiao XY; Bradford WW; Rich BE
    Bioorg Med Chem; 2005 Jul; 13(13):4269-78. PubMed ID: 15869881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.
    Granato M; Chiozzi B; Filardi MR; Lotti LV; Di Renzo L; Faggioni A; Cirone M
    Cancer Lett; 2015 Oct; 366(2):191-7. PubMed ID: 26184999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinases are required for interferon-gamma-stimulated proliferation of Trypanosoma brucei brucei.
    Mustafa E; Bakhiet M; Jaster R; Bittorf T; Mix E; Olsson T
    J Infect Dis; 1997 Mar; 175(3):669-73. PubMed ID: 9041340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs.
    Dai X; Wang Y; Li Y; Zhong Y; Pei M; Long J; Dong X; Chen YL; Wang Q; Wang G; Gold BG; Vandenbark AA; Neve KA; Offner H; Wang C
    Life Sci; 2022 Apr; 294():120383. PubMed ID: 35143827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
    George J; Barshack I; Goldberg I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
    Exp Mol Pathol; 2004 Jun; 76(3):234-41. PubMed ID: 15126106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.